However, it is not all rosy news with this protein
Microscopically, transmural hyperemia of the gastrointestinal tract, intestinal mucosa villi reduction, crypt reduction with focal denudation of superficial epithelia, and large bowel dilatation were all inhibited
This makes it uniquely suited for tackling memory loss, Alzheimer's disease, traumatic brain injury (TBI), and even optimizing healthy cognitive performance
On the same day as the preprint appeared, 16 March, the manuscript was submitted to the International Journal of Antimicrobial Agents, where it was accepted within a day, on 17 March, and published online on 20 March
Let's just look for a moment at what the Peptide Therapy Clinic and Pharmacy has said about this peptide